Societal CDMO Inc
NASDAQ:SCTL
Societal CDMO Inc
Revenue
Societal CDMO Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Societal CDMO Inc
NASDAQ:SCTL
|
Revenue
$94.6m
|
CAGR 3-Years
12%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Revenue
$81.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Revenue
$45B
|
CAGR 3-Years
2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
|
Pfizer Inc
NYSE:PFE
|
Revenue
$58.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
1%
|
|
Merck & Co Inc
NYSE:MRK
|
Revenue
$60.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
Eli Lilly and Co
NYSE:LLY
|
Revenue
$34.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
See Also
What is Societal CDMO Inc's Revenue?
Revenue
94.6m
USD
Based on the financial report for Dec 31, 2023, Societal CDMO Inc's Revenue amounts to 94.6m USD.
What is Societal CDMO Inc's Revenue growth rate?
Revenue CAGR 5Y
4%
Over the last year, the Revenue growth was 5%. The average annual Revenue growth rates for Societal CDMO Inc have been 12% over the past three years , 4% over the past five years .